SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001072613-15-000002
Filing Date
2015-01-02
Accepted
2015-01-02 10:25:28
Documents
1
Group Members
ANTHONY A. FLORENCE JR.DAVID M. MOTTFOREST BASKETTHARRY R. WELLERKRISHNA S. KOLLURIMICHAEL JAMES BARRETTNEA 14 GP LTDNEA PARTNERS 14 L.P.NEW ENTERPRISE ASSOCIATES 14 L.P.PATRICK J. KERINSPETER J. BARRISPETER W. SONSINIRAVI VISWANATHANRYAN D. DRANTSCOTT D.

Document Format Files

Seq Description Document Type Size
1 INTERLEUKIN GENETICS interleukin-sch13da_17738.htm SC 13D/A 518566
  Complete submission text file 0001072613-15-000002.txt   520684
Mailing Address 135 BEAVER ST WATHAM MA 02452
Business Address 135 BEAVER ST WATHAM MA 02452 1-781-398-0700
INTERLEUKIN GENETICS INC (Subject) CIK: 0001037649 (see all company filings)

IRS No.: 943123681 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-53249 | Film No.: 15500388
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 1954 GREENSPRING DRIVE SUITE 600 TIMONIUM MD 21093
Business Address 1954 GREENSPRING DRIVE SUITE 600 TIMONIUM MD 21093 410-842-4000
Growth Equity Opportunities Fund III, LLC (Filed by) CIK: 0001551055 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A